ReqMed logo

ReqMed

Website
Current Valuation
$42.4M
As of June 16, 2025
Total Funding Raised
$9.0M
Last Round
Later Stage VC

$9.0M

Last Funding
Jun 2025

Funding date

Capital Efficiency
4.71x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

ReqMed is currently valued at $42.4M as of June 16, 2025. The company has raised a total of $9.0M in funding.

Capital Efficiency

With a capital efficiency ratio of 4.71x, ReqMed has achieved a valuation that is 4.71 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.

Investment Perspective

ReqMed's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track ReqMed Valuation Updates

Get notified when ReqMed raises new funding or valuation changes

Explore More Data
Detailed analysis for ReqMed

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is ReqMed Worth in 2025?

As of 2025, ReqMed is valued at $42.4M, based on the company's Later Stage VC funding round in June 16, 2025. This valuation positions ReqMed as one of the leading private companies in the sector.

ReqMed Valuation History

ReqMed's funding history demonstrates steady growth and investor confidence.

How ReqMed Valuation is Determined

Private company valuations like ReqMed's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

ReqMed Valuation FAQs

Is ReqMed profitable?

ReqMed has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does ReqMed's valuation compare to competitors?

ReqMed is valued at $42.4M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will ReqMed IPO?

ReqMed has not announced plans for an initial public offering. Until an IPO, investors can access ReqMed shares through secondary market platforms.